Log In Sign up
The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > TiterMax

TiterMax

TiterMax is a powerful tool that helps researchers optimize their experimental protocols using AI-driven technology.
The platform allows users to easily locate the best procedures from scientific literature, preprints, and patents, and then utilize intelligent comparisons to identify the most accurate and reproducible methods.
By leveraging PubCompare.ai's leading solution for protocol optimizatin, researchers can boost the quality and confidence of their experiments.
This concise and informative overview outlines how TiterMax's AI-driven platform can support your research effeorts.

Most cited protocols related to «TiterMax»

1
Lamprey Immune Response Protocol
Cited 7 times
Sea lamprey larvae (8–15 cm, 2–4 years of age) were collected from tributaries to Lake Michigan (Lamprey services, Michigan) and housed in sand-lined aquariums at 20°C. Larvae anesthetized with 0.1 g/l MS222 (Sigma) were given intracoelomic injections of antigens or mitogens (25 µg phytohemaglutinin (PHA)-L (Sigma)) prepared in 60 µl of sterile 0.67X PBS. Injections were administered on days 0 and 14, and tissues collected from lampreys euthanized with 1 g/l MS222 on day 28 (unless otherwise indicated). Blood was collected in 30 mM EDTA/0.67X PBS. Buffy coat leukocytes were separated from red blood cells by centrifugation at 50×g. Leukocytes were isolated from kidney, typhlosole, and gills by disrupting tissues between frosted glass slides.
For VLRA antibody production, four VLRA cDNAs isolated from lamprey lymphocytes were cloned in-frame with the constant region of human IgG1 (IgG1-Fc). The VLRA-IgG1-Fc fusion proteins were expressed in HEK-293T cells and purified from tissue culture supernatants by protein A (GE Healthcare) chromatography. Monoclonal anti-VLRA antibodies were produced by immunization of BALB/c mice with VLRA-IgG1-Fc proteins emulsified in TiterMax Gold adjuvant. Lymphocytes from the draining lymph nodes of immunized mice were fused with the Ag8.653 myeloma cell line using PEG-1500 (Roche). Three VLRA-specific hybridoma clones (9A6 (IgG1), 9B3 (IgG1) and 2A5 (IgG1)) were identified by ELISA with VLRA recombinant protein and immunoblotting of VLRA transfectants. Anti-VLRA polyclonal antisera were produced by immunization of rabbits with the VLRA-IgG1-Fc proteins (PickCell Laboratories BV, Netherlands).
Guo P., Hirano M., Herrin B.R., Li J., Yu C., Sadlonova A, & Cooper M.D. (2009). Dual Nature of the Adaptive Immune System in Lampreys. Nature, 459(7248), 796-801.
Publication 2009
Antibody Formation Antigens BLOOD Cell Lines Centrifugation Chromatography Clone Cells DNA, Complementary Edetic Acid Enzyme-Linked Immunosorbent Assay Erythrocytes Gills Gold HEK293 Cells Homo sapiens Hybridomas IgG1 Immune Sera Kidney Lampreys Larva Leukocytes Lymphocyte Mice, Inbred BALB C Mitogens Monoclonal Antibodies Multiple Myeloma Mus Nodes, Lymph Oryctolagus cuniculus Petromyzon marinus Pharmaceutical Adjuvants Proteins Reading Frames Recombinant Proteins Staphylococcal Protein A Sterility, Reproductive Tissues TiterMax Vaccination
2
Peptide and DNA Immunization Protocols
Cited 5 times
The five peptides used in this study, HIV-10 (RGPGRAFVTI), SSI (SSIEFARL), SEI (SEIEFARL), TWH (TWHRYHLL), and TAY (TAYRYHLL), were synthesized by the Memorial Sloan Kettering Cancer Center Microchemistry Core Facility, and were HPLC purified to >98% purity. Peptide immunization using the synthetic immune adjuvant TiterMax (CytRx Inc., Norcross, GA), referred to as pep/TM in the text, CTL restimulation, and 51Cr-release assays were performed as previously described (19 (link)). In brief, mice were immunized in the footpad with 10 μl of the pep/TM emulsion (mixed according to the manufacturer's instructions) containing 5 μg of the indicated peptide. 7 d later, spleen cells from the immunized mice were restimulated in vitro with syngeneic, irradiated (30 Gy), peptide-coated (1 μg/ml, 2 ml/spleen, 1 h at 37°C followed by three washes) cells. 5 d later, cytolytic activity was assessed in a standard 51Cr-release assay. Genetic immunization using DNA-coated gold particles was performed exactly as previously described using a gene gun provided by Powderject, Inc. (Middleton, WI) (20 (link)). 100 μg of DNA from the plasmids described in the previous section was mixed with 0.95–2.6-μm diameter gold particles, in the presence of 0.05–0.1 μM spermidine. CaCl2 (1.5 mM) was added in a dropwise fashion to this mixture during vortexing. After precipitation, the gold plasmid DNA complex was washed three times in 100% ethanol and 7 ml of ethanol was added to achieve a bead-loading rate of 0.5 mg of gold to 1.0 μg plasmid DNA per injection. This solution was instilled into plastic Tefzel tubing, the ethanol was gently drawn off, and the tube was purged under nitrogen gas at 400 ml/min for drying. The tube was then cut into 0.5-inch bullets. The gold particles in the “bullets” were injected into the skin of anesthetized mice using a helium-driven gene gun (Powderject, Inc.). The skin was shaved and depilated before injection (20 (link)). Four injections at 400 pounds/square inch were delivered to each mouse, one to each of the abdominal quadrants, for a total of 4 μg of plasmid DNA per mouse. 7 d later, spleen cells were restimulated and CTL activity was determined as described for pep/TM.
Dyall R., Bowne W.B., Weber L.W., LeMaoult J., Szabo P., Moroi Y., Piskun G., Lewis J.J., Houghton A.N, & Nikolić-Žugić J. (1998). Heteroclitic Immunization Induces Tumor Immunity. The Journal of Experimental Medicine, 188(9), 1553-1561.
Publication 1998
Abdomen Biological Assay Cells Emulsions Ethanol Genes Gold Helium High-Performance Liquid Chromatographies Immunologic Adjuvants iroxanadine Malignant Neoplasms Mus Nitrogen P18-I10 peptide Peptides Plasmids Skin Spermidine Spleen Tefzel TiterMax Vaccination Vaccines, Peptide
3
Rabbit Immunization and Antibody Purification
Cited 4 times
New Zealand white rabbits (Harlan Laboratories, Prattville, AL) were initially immunized with 100 µg of purified GST-TIP-1 protein premixed in a 1∶1 ratio by weight with Titermax adjuvant (CytRx Corporation, Los Angeles, CA). One month after the initial immunization, the animals were boosted with same amount of antigen twice with 2 weeks interval without the adjuvant. Blood samples were periodically taken for antibody titration and specificity analyses by ELISA or western blot. When the anti-TIP-1 antibody reached the designated high titer, the animals were sacrificed to collect the antiserum. The antiserum was purified by passage through protein A plus protein G columns (sigma) to purify IgGs. TIP-1 specific antibodies were prepared from the purified IgGs by tandem absorption with bacterial proteins and the purified GST protein-conjugated sepharose-4B (Sigma) to remove the IgGs that might bind proteins other than TIP-1. The final antibody was dialyzed against PBS and concentrated via Amicon centrifugal filters (Millipore, Billerica, MA). Specificity of the TIP-1 specific antibody was validated with whole cell staining and western blot analyses of whole cell lysates. All animal studies were conducted as approved (protocol ID: M/08/051 and M/08/592) by the Institutional Animal Care and Use Committee (IACUC) at Vanderbilt University.
Wang H., Yan H., Fu A., Han M., Hallahan D, & Han Z. (2010). TIP-1 Translocation onto the Cell Plasma Membrane Is a Molecular Biomarker of Tumor Response to Ionizing Radiation. PLoS ONE, 5(8), e12051.
Full text: Click here
Publication 2010
Animals Antibodies Antibodies, Anti-Idiotypic Antibody Specificity Antigens Bacterial Proteins BLOOD Cells Enzyme-Linked Immunosorbent Assay G-substrate Immune Sera Immunization Immunoglobulins Institutional Animal Care and Use Committees iroxanadine New Zealand Rabbits Pharmaceutical Adjuvants Proteins Sepharose 4B TiterMax Titrimetry Western Blot Western Blotting
4
Generation and Characterization of Anti-human DO mAbs
Cited 4 times
Anti–human mAbs used for FACS analyses were as follows: mouse IgG1-FITC (isotype control), PE-conjugated anti-CD19 and -CD38, Cy-Chrome® (Cyc) and allophycoerythrin-conjugated anti-CD38 and biotinylated anti-CD80 (B7.1) and -CD86 (B7.2) (all obtained from BD PharMingen). FITC- and PE-conjugated anti-IgD and -IgG (Southern Biotech). Biotinylated mAbs were detected with Streptavidin-CyC (BD PharMingen). Purified mAbs used for T cell depletions, anti-CD3 (OKT-3), -CD4 (Leu3a) and -CD8 (OKT-8), were purchased from the mAb Core Facility at Memorial Sloan-Kettering Cancer Center (MSKCC). The following mAbs were purified from bioreactor supernatants using standard protein G–Sepharose (Amersham Pharmacia Biotech) or protein A–Sepharose (Sigma-Aldrich) affinity chromatography: Mags.DO5, MaP.DM1 (6 (link)), L243 (11 (link)), CerCLIP.1 (11 (link)), and 3D3 (12 (link)), and conjugated with FITC or biotin as described previously (13 ).
To produce anti-human DO mAbs, mice were immunized with affinity-purified DM–DO complexes (10 (link)) emulsified in Titer Max (CytRx Corp.) and screened for an immune response by ELISA. Splenocytes were fused to SP2/O-Ag14 cells, and culture supernatants from the hybridoma cells were screened by immunofluorescence using DO positive and negative B cells. One hybridoma secreted an mAb that recognized DO. This clone (Mags.DO5; IgG1), recognizes free DO in addition to DM–DO complexes.
Glazier K.S., Hake S.B., Tobin H.M., Chadburn A., Schattner E.J, & Denzin L.K. (2002). Germinal Center B Cells Regulate Their Capability to Present Antigen by Modulation of HLA-DO. The Journal of Experimental Medicine, 195(8), 1063-1069.
Publication 2002
anti-IgD B-Lymphocytes Bioreactors Biotin Cell Culture Techniques Cells Chromatography, Affinity Clone Cells Enzyme-Linked Immunosorbent Assay Fluorescein-5-isothiocyanate G-substrate galiximab Homo sapiens Hybridomas IgG1 Immunofluorescence Immunoglobulin Isotypes iroxanadine MAG protein, human Malignant Neoplasms Muromonab-CD3 Mus Response, Immune Sepharose Staphylococcal protein A-sepharose Streptavidin T-Lymphocyte TiterMax
5
Monoclonal Antibody Generation Against SARS-CoV-2 RBD
Cited 3 times
The animal studies were approved by the Institutional Animal Care and Use Committee at the Institut Pasteur of Shanghai. The mice were kept in the SPF (specific pathogen free) animal facility with controlled temperature (20–26 °C), humidity (40–70%), and lighting conditions (12 h light/12 h dark cycle).
To generate MAbs, female BALB/c mice aged 6–8 weeks were each primed with 100 μg of RBD-mFc protein (Sino Biological) formulated with 0.5 mg of aluminum hydroxide adjuvant (Invivogen, USA) and 25 μg of CpG oligonucleotides (Sangon Biotech, China) via the i.p. route on day 0. The mice were boosted via the subcutaneous route on day 8 with RBD-mFc (50 μg/mouse) emulsified with Freund’s complete adjuvant (Sigma), and on day 13 with RBD-mFc (50 μg/mouse) emulsified with Titermax adjuvant (Sigma). On day 22, one mouse was injected with 75 μg of HEK 293F-expressed RBD protein in PBS in a tail vein. On day 26, splenocytes were isolated and fused with SP2/0 cells using polyethylene glycol 1450 (Sigma). Fused cells were then selected in a hypoxanthine, aminopterine, and thymidine (HAT; Sigma) medium. Eight days later, hybridoma supernatants were screened for their ability to bind to RBD protein and to block the ACE2-hFc/SARS-CoV-2 RBD binding by ELISA, as described below. ELISA-positive hybridoma cells were cloned by limiting dilution method and the resulting monoclonal cell lines were expanded. Purified MAbs were prepared from ascitic fluids using HiTrap™ Protein G HP column (GE Healthcare, USA).
Zhang C., Wang Y., Zhu Y., Liu C., Gu C., Xu S., Wang Y., Zhou Y., Wang Y., Han W., Hong X., Yang Y., Zhang X., Wang T., Xu C., Hong Q., Wang S., Zhao Q., Qiao W., Zang J., Kong L., Wang F., Wang H., Qu D., Lavillette D., Tang H., Deng Q., Xie Y., Cong Y, & Huang Z. (2021). Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nature Communications, 12, 264.
Full text: Click here
Publication 2021
ACE2 protein, human Aminopterin Animals Ascitic Fluid Biopharmaceuticals Cardiac Arrest Cell Lines Cells CPG-oligonucleotide Enzyme-Linked Immunosorbent Assay Females Freund's Adjuvant G-substrate Humidity Hybridomas Hydroxide, Aluminum Hypoxanthine Institutional Animal Care and Use Committees isononanoyl oxybenzene sulfonate Mice, Inbred BALB C Monoclonal Antibodies Mus Pharmaceutical Adjuvants Polyethylene Glycols Proteins SARS-CoV-2 Specific Pathogen Free Tail Technique, Dilution Thymidine TiterMax Veins

Most recents protocols related to «TiterMax»

1
Llama Immunization with Recombinant PD-L2
Not available on PMC !

EXAMPLE 23

One llama (No. 149) was immunized with 6 boosts (100 or 50 μg/dose at weekly intervals) of R&D Systems (Minneapolis, MN, US) Cat #1224-PL, which is the ectodomain of human PD-L2 (rhPDL2-Fc), formulated in Titermax Gold (Titermax USA, Norcross, GA, US), according to standard protocols. At week 4, sera were collected to define antibody titers against PD-L2 by ELISA. In short, 96-well Maxisorp plates (Nunc Wiesbaden, Germany) were coated with rhPDL2-Fc. After blocking and adding diluted sera samples, the presence of anti-PD-L2 Nanobodies was demonstrated by using rabbit anti-llama immunoglobulin antiserum and anti-rabbit immunoglobulin alkaline phosphatase conjugate. The titer exceeded 16000.

US11858997B2. Amino acid sequences that modulate the interaction between cells of the immune system (2024-01-02). Ablynx N.V. [BE]. Inventors: Guy Hermans [BE], Peter Verheesen [BE], Edward Dolk [NL], Hendricus Renerus Jacobus Mattheus Hoogenboom [NL], Michael John Scott Saunders [BE], Hans De Haard [NL], Renee de Bruin [NL].
Full text: Click here
Patent 2024
Alkaline Phosphatase Antibodies, Anti-Idiotypic Enzyme-Linked Immunosorbent Assay Gold Homo sapiens Immune Sera Immunization Immunoglobulins Llamas Rabbits Serum TiterMax VHH Immunoglobulin Fragments
2
Llama Immunization for Anti-PD1 Nanobodies
Not available on PMC !

EXAMPLE 11

Two llamas (No. 146 and No. 147) were immunized with 6 boosts (100 or 50 μg/dose at weekly intervals) of R&D Systems (Minneapolis, MN, US) Cat #1086-PD, which is the ectodomain of human PD1 (rhPD1-Fc), formulated in Titermax Gold (Titermax USA, Norcross, GA, US), according to standard protocols. At week 4, sera were collected to define antibody titers against PD-1 by ELISA. In short, 96-well Maxisorp plates (Nunc Wiesbaden, Germany) were coated with rhPD1-Fc. After blocking and adding diluted sera samples, the presence of anti-PD-1 Nanobodies was demonstrated by using rabbit anti-llama immunoglobulin antiserum and anti-rabbit immunoglobulin alkaline phosphatase conjugate. The titer exceeded 16000 for both animals.

US11858997B2. Amino acid sequences that modulate the interaction between cells of the immune system (2024-01-02). Ablynx N.V. [BE]. Inventors: Guy Hermans [BE], Peter Verheesen [BE], Edward Dolk [NL], Hendricus Renerus Jacobus Mattheus Hoogenboom [NL], Michael John Scott Saunders [BE], Hans De Haard [NL], Renee de Bruin [NL].
Full text: Click here
Patent 2024
Alkaline Phosphatase Animals Antibodies, Anti-Idiotypic Enzyme-Linked Immunosorbent Assay Gold Homo sapiens Immune Sera Immunization Immunoglobulins Llamas Rabbits Serum TiterMax VHH Immunoglobulin Fragments
3
Immunization with Recombinant CD22 Extracellular Domain
Not available on PMC !

Example 2

Immunization with Recombinant Extracellular Domain of CD22.

Twelve UniRat animals (6 HC27, 6 HC28) were immunized with recombinant human CD22 protein. The animals were immunized according to standard protocol using a Titermax/Alhydrogel adjuvant. Recombinant extracellular domain of CD22 was purchased from R&D Systems and was diluted with sterile saline and combined with adjuvant. The immunogen was combined with Titermax and Alhydrogel adjuvants. The first immunization (priming) with immunogen in Titermax was administered in the left and right legs. Subsequent boosting immunizations were done in the presence of Alhydrogel and three days before harvest boosts were performed with immunogens in PBS. Serum was collected from rats at the final bleed to determine serum titers.

Serum Titer Results

Serum titer summary information is shown in FIG. 6. In the graphs depicted in FIG. 6, each line represents an individual animal. The legends of the graphs show the ID number of each individual animal Binding activity for an 8-point dilution series of serum was tested by ELISA against a huCD22+Fc protein, huCD22+His tag, rhesus CD22+His tag protein protein, and a His tag off-target protein. Among this group of animals, a range of serum reactivity levels to both human and rhesus CD22 protein was observed. A serum response to the His protein tag was also observed.

US11873336B2. Heavy chain antibodies binding to CD22 (2024-01-16). TeneoBio, Inc. [US]. Inventors: Shelley Force Aldred [US], Wim van Schooten [US], Heather Anne N. Ogana [US], Laura Marie Davison [US], Katherine Harris [US], Udaya Rangaswamy [US], Nathan D. Trinklein [US].
Full text: Click here
Patent 2024
Alhydrogel Animals Antigens CD22 protein, human Enzyme-Linked Immunosorbent Assay Homo sapiens Immunization Leg Macaca mulatta Pharmaceutical Adjuvants Proteins Protein Targeting, Cellular Rattus norvegicus Saline Solution Serum Staphylococcal Protein A Sterility, Reproductive Technique, Dilution TiterMax Vaccination Vaccines, Recombinant
4
Immunization and Antibody Titer Assay for B7-H2
Not available on PMC !

EXAMPLE 29

One llama (No. 149) was immunized with 6 boosts (100 or 50 μg/dose at weekly intervals) of R&D Systems (Minneapolis, MN, US) Cat #165-B7, which is the ectodomain of human B7-H2 (rhB7-H2-Fc), formulated in Titermax Gold (Titermax USA, Norcross, GA, US), according to standard protocols. At week 4, sera were collected to define antibody titers against B7-H2 by ELISA. In short, 96-well Maxisorp plates (Nunc Wiesbaden, Germany) were coated with rhB7-H2-Fc. After blocking and adding diluted sera samples, the presence of anti-B7-H2 Nanobodies was demonstrated by using rabbit anti-llama immunoglobulin antiserum and anti-rabbit immunoglobulin alkaline phosphatase conjugate. The titer exceeded 16000.

US11858997B2. Amino acid sequences that modulate the interaction between cells of the immune system (2024-01-02). Ablynx N.V. [BE]. Inventors: Guy Hermans [BE], Peter Verheesen [BE], Edward Dolk [NL], Hendricus Renerus Jacobus Mattheus Hoogenboom [NL], Michael John Scott Saunders [BE], Hans De Haard [NL], Renee de Bruin [NL].
Full text: Click here
Patent 2024
Alkaline Phosphatase Antibodies, Anti-Idiotypic Enzyme-Linked Immunosorbent Assay Gold Homo sapiens ICOSLG protein, human Immune Sera Immunization Immunoglobulins Llamas Rabbits Serum TiterMax VHH Immunoglobulin Fragments
5
Llama Anti-B7-H1 Nanobody Protocol
Not available on PMC !

EXAMPLE 17

One llama (No. 149) was immunized with 6 boosts (100 or 50 μg/dose at weekly intervals) of R&D Systems (Minneapolis, MN, US) Cat #156-B7, which is the ectodomain of human B7-H1 (rh B7H1-Fc), formulated in Titermax Gold (Titermax USA, Norcross, GA, US), according to standard protocols. At week 4, sera were collected to define antibody titers against B7-H1 by ELISA. In short, 96-well Maxisorp plates (Nunc Wiesbaden, Germany) were coated with rh B7H1-Fc. After blocking and adding diluted sera samples, the presence of anti-B7-H1 Nanobodies was demonstrated by using rabbit anti-llama immunoglobulin antiserum and anti-rabbit immunoglobulin alkaline phosphatase conjugate. The titer exceeded 16000.

US11858997B2. Amino acid sequences that modulate the interaction between cells of the immune system (2024-01-02). Ablynx N.V. [BE]. Inventors: Guy Hermans [BE], Peter Verheesen [BE], Edward Dolk [NL], Hendricus Renerus Jacobus Mattheus Hoogenboom [NL], Michael John Scott Saunders [BE], Hans De Haard [NL], Renee de Bruin [NL].
Full text: Click here
Patent 2024
Alkaline Phosphatase Antibodies, Anti-Idiotypic CD274 protein, human Enzyme-Linked Immunosorbent Assay Gold Homo sapiens Immune Sera Immunization Immunoglobulins Llamas Rabbits Serum TiterMax VHH Immunoglobulin Fragments

Top products related to «TiterMax»

1
Titermax gold adjuvant by Merck Group
Sourced in United States, Germany
TiterMax Gold adjuvant is a laboratory reagent that enhances the immune response in immunological assays. It is a water-in-oil emulsion that can be used to stimulate the production of antibodies in various experimental models. The core function of TiterMax Gold is to act as an adjuvant, which is a substance that is added to vaccines or immunological assays to improve the body's immune response to the target antigen.
2
Titermax gold by Merck Group
Sourced in United States
TiterMax Gold is a laboratory reagent used in immunochemistry and cell biology applications. It is designed to enhance the binding of antigens to antibodies, facilitating the detection and quantification of specific molecules in samples. The product functions as an adjuvant, improving the sensitivity and performance of immunoassays.
3
Maxisorp plate by Thermo Fisher Scientific
Sourced in Denmark, United States, Germany, United Kingdom, Canada
Maxisorp plates are a type of microwell plate designed for immunoassays. They feature a high-binding surface that allows for efficient capture of proteins and other biomolecules. The plates are made of polystyrene and are available in a variety of well configurations to suit different experimental needs.
4
Titermax by Merck Group
Sourced in United States
TiterMax is a laboratory equipment product manufactured by Merck Group. It is used for quantitative analysis and determination of antibody titers in biological samples. The core function of TiterMax is to accurately measure and analyze the concentration of specific antibodies present in a given sample.
5
Titer max classic adjuvant by Merck Group
Sourced in United States
Titer-Max Classic is a laboratory adjuvant product manufactured by Merck Group. It is designed to enhance the immune response in various experimental settings. The product functions as an adjuvant, which is a substance that helps stimulate and strengthen the body's immune response to a specific antigen or vaccine.
6
Expicho expression system by Thermo Fisher Scientific
Sourced in United States
The ExpiCHO Expression System is a cell culture-based platform for the production of recombinant proteins using Chinese Hamster Ovary (CHO) cells. The system provides a streamlined workflow for rapid and efficient protein expression and production.
7
Peg1500 by Roche
Sourced in United States, Switzerland, Germany
PEG1500 is a polyethylene glycol compound with a molecular weight of 1,500 Daltons. It is a commonly used reagent in various laboratory applications, including protein purification, drug delivery, and enzyme conjugation.
8
Titermax adjuvant by Merck Group
Sourced in United States
TiterMax adjuvant is a laboratory reagent used to enhance the immune response in immunological assays and vaccine development. It is a water-in-oil emulsion that acts as an adjuvant to boost the efficacy of immunogens. The core function of TiterMax is to stimulate and modulate the immune system, leading to increased antibody production and cell-mediated immune responses.
9
Titermax gold adjuvant liquid by Merck Group
TiterMax® Gold Adjuvant is a liquid formulation designed to enhance immune responses in laboratory animal studies. It is a proprietary adjuvant system that can be used to increase the potency of vaccines or other immunogenic preparations.
10
Expicho cells by Thermo Fisher Scientific
Sourced in United States
ExpiCHO cells are a mammalian cell line designed for use in the transient production of recombinant proteins. They are derived from Chinese Hamster Ovary (CHO) cells and are optimized for high-yield protein expression.

More about "TiterMax"

TiterMax is a powerful AI-driven platform that helps researchers optimize their experimental protocols.
The platform allows users to easily locate the best procedures from scientific literature, preprints, and patents, and then utilize intelligent comparisons to identify the most accurate and reproducible methods.
By leveraging PubCompare.ai's leading solution for protocol optimization, researchers can boost the quality and confidence of their experiments.
TiterMax's AI-driven technology is a game-changer for researchers working with a variety of tools and techniques, including TiterMax Gold adjuvant, TiterMax Gold, Maxisorp plates, Titer-Max Classic adjuvant, ExpiCHO Expression System, PEG1500, and TiterMax adjuvant.
The TiterMax® Gold Adjuvant liquid is a particularly useful tool for enhancing immune responses in experiments.
With TiterMax, researchers can quickly and easily find the most effective protocols, reducing the time and effort required to achieve reliable and reproducible results.
The platform's intelligent comparison features allow users to identify the most accurate methods, boosting the quality and confidence of their research efforts.
Whether you're working with cell lines like ExpiCHO cells or exploring new experimental techniques, TiterMax's AI-driven platform can be a valuable asset in your research toolbox.
By leveraging the latest advancements in protocol optimization, you can take your experiments to the next level and drive your research forward with greater efficiency and confidence.